Takeda And Orexigen Announce FDA Approval of Contrave Extended-release Tablets For Chronic Weight Management
September 11, 2014 at 07:01 AM EDT
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that the U.S. Food and Drug ...